In our study, the poor survival of MPNST patients receiving LSS could be attributed to the agressivity of the disease, high recurrence, and lack of chemosensibility due to mutation of the NF1 gene (35, 36). Here, NF1 is linked to malignant peripheral nerve sheath tumor.